Russell Investments Group’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.21M Buy
40,266
+5,356
+15% +$1.2M 0.01% 986
2025
Q4
$7.44M Sell
34,910
-6,549
-16% -$1.35M 0.01% 1084
2025
Q3
$8.24M Buy
41,459
+12,092
+41% +$2.26M 0.01% 999
2025
Q2
$5.07M Buy
29,367
+5,621
+24% +$916K 0.01% 1205
2025
Q1
$3.7M Buy
23,746
+20,532
+639% +$2.93M 0.01% 1337
2024
Q4
$442K Buy
3,214
+6
+0.2% +$789 ﹤0.01% 2310
2024
Q3
$479K Hold
3,208
﹤0.01% 2288
2024
Q2
$438K Hold
3,208
﹤0.01% 2247
2024
Q1
$485K Hold
3,208
﹤0.01% 2209
2023
Q4
$404K Sell
3,208
-4,166
-56% -$415K ﹤0.01% 2288
2023
Q3
$691K Sell
7,374
-40,252
-85% -$3.77M ﹤0.01% 2107
2023
Q2
$4.25M Sell
47,626
-6,577
-12% -$572K 0.01% 1167
2023
Q1
$5.81M Sell
54,203
-4,760
-8% -$545K 0.01% 1038
2022
Q4
$7.2M Sell
58,963
-7,239
-11% -$840K 0.01% 915
2022
Q3
$6.83M Buy
66,202
+16,970
+34% +$1.61M 0.02% 900
2022
Q2
$4.58M Buy
49,232
+12,447
+34% +$1.17M 0.01% 1145
2022
Q1
$4.32M Buy
36,785
+10,332
+39% +$1.2M 0.01% 1244
2021
Q4
$3.56M Buy
26,453
+998
+4% +$148K 0.01% 1471
2021
Q3
$4.06M Buy
25,455
+5,214
+26% +$714K 0.01% 1373
2021
Q2
$2.66M Buy
+20,241
New +$2.7M ﹤0.01% 1743

Other funds holding ASND